v3.24.4
Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-in Capital
Subscription Receivable
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 87 $ 2,119,073 $ (37,500) $ (12,255) $ 2,069,405
Balance (in Shares) at Dec. 31, 2021   868,154          
Proceeds from subscriptions receivable 37,500 37,500
Net loss (1,421,172) (1,421,172)
Balance at Dec. 31, 2022 $ 87 2,119,073 (1,433,427) 685,733
Balance (in Shares) at Dec. 31, 2022   868,154          
Common shares and warrants issued for cash, net $ 14 5,755,857   5,755,871
Common shares and warrants issued for cash, net (in Shares)   140,563          
Accretion of stock option expense 870,572   870,572
Accumulated other comprehensive gain - short-term investments   18,156 18,156
Net loss   (1,536,031) (1,536,031)
Balance at Mar. 31, 2023 $ 101 8,745,502   18,156 (2,969,458) 5,794,301
Balance (in Shares) at Mar. 31, 2023   1,008,717          
Balance at Dec. 31, 2022 $ 87 2,119,073 (1,433,427) 685,733
Balance (in Shares) at Dec. 31, 2022   868,154          
Net loss             (3,147,134)
Balance at Sep. 30, 2023 $ 91 8,739,656   79,646 (4,580,561) 4,238,832
Balance (in Shares) at Sep. 30, 2023   902,786          
Balance at Dec. 31, 2022 $ 87 2,119,073 (1,433,427) 685,733
Balance (in Shares) at Dec. 31, 2022   868,154          
Common shares and warrants issued for cash, net $ 14 5,755,857 5,755,871
Common shares and warrants issued for cash, net (in Shares)   140,563          
Purchase and cancellation of treasury stock $ (2) (99,734) (99,736)
Purchase and cancellation of treasury stock (in Shares)   (20,349)          
Accretion of stock option expense 936,354 936,354
Accumulated other comprehensive gain - short-term investments 95,785 95,785
Net loss (3,948,097) (3,948,097)
Balance at Dec. 31, 2023 $ 99 8,711,550 95,785 (5,381,524) 3,425,910
Balance (in Shares) at Dec. 31, 2023   988,368          
Balance at Mar. 31, 2023 $ 101 8,745,502   18,156 (2,969,458) 5,794,301
Balance (in Shares) at Mar. 31, 2023   1,008,717          
Purchase and cancellation of treasury stock $ (3) (24,238)   (24,241)
Purchase and cancellation of treasury stock (in Shares)   (32,048)          
Accretion of stock option expense 21,927   21,927
Accumulated other comprehensive gain - short-term investments   19,649 19,649
Net loss   (754,044) (754,044)
Balance at Jun. 30, 2023 $ 98 8,743,191   37,805 (3,723,502) 5,057,592
Balance (in Shares) at Jun. 30, 2023   976,669          
Purchase and cancellation of treasury stock $ (7) (25,462)   (25,469)
Purchase and cancellation of treasury stock (in Shares)   (73,883)          
Accretion of stock option expense 21,927   21,927
Accumulated other comprehensive gain - short-term investments   41,841 41,841
Net loss   (857,059) (857,059)
Balance at Sep. 30, 2023 $ 91 8,739,656   79,646 (4,580,561) 4,238,832
Balance (in Shares) at Sep. 30, 2023   902,786          
Balance at Dec. 31, 2023 $ 99 8,711,550 95,785 (5,381,524) 3,425,910
Balance (in Shares) at Dec. 31, 2023   988,368          
Common shares and warrants issued for cash, net $ 11 159,049   159,060
Common shares and warrants issued for cash, net (in Shares)   108,000          
Purchase and cancellation of treasury stock $ (1) (19,601)   (19,602)
Purchase and cancellation of treasury stock (in Shares)   (6,846)          
Accretion of stock option expense 15,806   15,806
Accumulated other comprehensive gain - short-term investments   (99,414) (99,414)
Sale of pre-funded warrants for cash 2,897,924   2,897,924
Rounding shares from reverse split (in Shares)   4,150          
Net loss   (912,145) (912,145)
Balance at Mar. 31, 2024 $ 109 11,764,728   (3,629) (6,293,669) 5,467,539
Balance (in Shares) at Mar. 31, 2024   1,093,672          
Balance at Dec. 31, 2023 $ 99 8,711,550 95,785 (5,381,524) 3,425,910
Balance (in Shares) at Dec. 31, 2023   988,368          
Net loss             (2,585,793)
Balance at Sep. 30, 2024 $ 189 14,668,396   13,299 (7,967,317) 6,714,567
Balance (in Shares) at Sep. 30, 2024   1,892,773          
Balance at Mar. 31, 2024 $ 109 11,764,728   (3,629) (6,293,669) 5,467,539
Balance (in Shares) at Mar. 31, 2024   1,093,672          
Common shares issued for warrant exercise $ 11 93   104
Common shares issued for warrant exercise (in Shares)   103,367          
Accretion of stock option expense 33,435   33,435
Accumulated other comprehensive gain - short-term investments   7,044 7,044
Net loss   (809,238) (809,238)
Balance at Jun. 30, 2024 $ 120 11,798,256   3,415 (7,102,907) 4,698,884
Balance (in Shares) at Jun. 30, 2024   1,197,039          
Common shares issued for exercise of March 2024 Common Warrants for cash under warrants inducement offer, net $ 27 2,834,816   2,834,843
Common shares issued for exercise of March 2024 Common Warrants for cash under warrants inducement offer, net (in Shares)   278,734          
Common shares issued for Pre-funded warrant exercises $ 42 375   417
Common shares issued for Pre-funded warrant exercises (in Shares)   417,000          
Accretion of stock option expense 34,949   34,949
Accumulated other comprehensive gain - short-term investments   9,884 9,884
Net loss   (864,410) (864,410)
Balance at Sep. 30, 2024 $ 189 $ 14,668,396   $ 13,299 $ (7,967,317) $ 6,714,567
Balance (in Shares) at Sep. 30, 2024   1,892,773